Cargando…

The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward

INTRODUCTION: Oral pre‐exposure prophylaxis (PrEP) is a new form of HIV prevention being considered for inclusion in national prevention portfolios. Many mathematical modelling studies have been undertaken that speak to the impact, cost and cost‐effectiveness of PrEP programmes. We assess the availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Case, Kelsey K, Gomez, Gabriela B, Hallett, Timothy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753289/
https://www.ncbi.nlm.nih.gov/pubmed/31538407
http://dx.doi.org/10.1002/jia2.25390
_version_ 1783452871271907328
author Case, Kelsey K
Gomez, Gabriela B
Hallett, Timothy B
author_facet Case, Kelsey K
Gomez, Gabriela B
Hallett, Timothy B
author_sort Case, Kelsey K
collection PubMed
description INTRODUCTION: Oral pre‐exposure prophylaxis (PrEP) is a new form of HIV prevention being considered for inclusion in national prevention portfolios. Many mathematical modelling studies have been undertaken that speak to the impact, cost and cost‐effectiveness of PrEP programmes. We assess the available evidence from mathematical modelling studies to inform programme planning and policy decision making for PrEP and further research directions. METHODS: We conducted a scoping review of the published modelling literature. Articles published in English which modelled oral PrEP in sub‐Saharan Africa, or non‐specific settings with relevance to generalized HIV epidemic settings, were included. Data were extracted for the strategies of PrEP use modelled, and the impact, cost and cost‐effectiveness of PrEP for each strategy. We define an algorithm to assess the quality and relevance of studies included, summarize the available evidence and identify the current gaps in modelling. Recommendations are generated for future modelling applications and data collection. RESULTS AND DISCUSSION: We reviewed 1924 abstracts and included 44 studies spanning 2007 to 2017. Modelling has reported that PrEP can be a cost‐effective addition to HIV prevention portfolios for some use cases, but also that it would not be cost‐effective to fund PrEP before other prevention interventions are expanded. However, our assessment of the quality of the modelling indicates cost‐effectiveness analyses failed to comply with standards of reporting for economic evaluations and the assessment of relevance highlighted that both key parameters and scenarios are now outdated. Current evidence gaps include modelling to inform service development using updated programmatic information and ex post modelling to evaluate and inform efficient deployment of resources in support of PrEP, especially among key populations, using direct evidence of cost, adherence and uptake patterns. CONCLUSIONS: Updated modelling which more appropriately captures PrEP programme delivery, uses current intervention scenarios, and is parameterized with data from demonstration and implementation projects is needed in support of more conclusive findings and actionable recommendations for programmes and policy. Future analyses should address these issues, aligning with countries to support the needs of programme planners and decision makers for models to more directly inform programme planning and policy.
format Online
Article
Text
id pubmed-6753289
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67532892019-09-23 The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward Case, Kelsey K Gomez, Gabriela B Hallett, Timothy B J Int AIDS Soc Reviews INTRODUCTION: Oral pre‐exposure prophylaxis (PrEP) is a new form of HIV prevention being considered for inclusion in national prevention portfolios. Many mathematical modelling studies have been undertaken that speak to the impact, cost and cost‐effectiveness of PrEP programmes. We assess the available evidence from mathematical modelling studies to inform programme planning and policy decision making for PrEP and further research directions. METHODS: We conducted a scoping review of the published modelling literature. Articles published in English which modelled oral PrEP in sub‐Saharan Africa, or non‐specific settings with relevance to generalized HIV epidemic settings, were included. Data were extracted for the strategies of PrEP use modelled, and the impact, cost and cost‐effectiveness of PrEP for each strategy. We define an algorithm to assess the quality and relevance of studies included, summarize the available evidence and identify the current gaps in modelling. Recommendations are generated for future modelling applications and data collection. RESULTS AND DISCUSSION: We reviewed 1924 abstracts and included 44 studies spanning 2007 to 2017. Modelling has reported that PrEP can be a cost‐effective addition to HIV prevention portfolios for some use cases, but also that it would not be cost‐effective to fund PrEP before other prevention interventions are expanded. However, our assessment of the quality of the modelling indicates cost‐effectiveness analyses failed to comply with standards of reporting for economic evaluations and the assessment of relevance highlighted that both key parameters and scenarios are now outdated. Current evidence gaps include modelling to inform service development using updated programmatic information and ex post modelling to evaluate and inform efficient deployment of resources in support of PrEP, especially among key populations, using direct evidence of cost, adherence and uptake patterns. CONCLUSIONS: Updated modelling which more appropriately captures PrEP programme delivery, uses current intervention scenarios, and is parameterized with data from demonstration and implementation projects is needed in support of more conclusive findings and actionable recommendations for programmes and policy. Future analyses should address these issues, aligning with countries to support the needs of programme planners and decision makers for models to more directly inform programme planning and policy. John Wiley and Sons Inc. 2019-09-19 /pmc/articles/PMC6753289/ /pubmed/31538407 http://dx.doi.org/10.1002/jia2.25390 Text en © 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Case, Kelsey K
Gomez, Gabriela B
Hallett, Timothy B
The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title_full The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title_fullStr The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title_full_unstemmed The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title_short The impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐Saharan Africa: a scoping review of modelling contributions and way forward
title_sort impact, cost and cost‐effectiveness of oral pre‐exposure prophylaxis in sub‐saharan africa: a scoping review of modelling contributions and way forward
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753289/
https://www.ncbi.nlm.nih.gov/pubmed/31538407
http://dx.doi.org/10.1002/jia2.25390
work_keys_str_mv AT casekelseyk theimpactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward
AT gomezgabrielab theimpactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward
AT halletttimothyb theimpactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward
AT casekelseyk impactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward
AT gomezgabrielab impactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward
AT halletttimothyb impactcostandcosteffectivenessoforalpreexposureprophylaxisinsubsaharanafricaascopingreviewofmodellingcontributionsandwayforward